diphenylamine has been researched along with Head and Neck Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter-Cooper, BA; Cullen, KJ; Dan, H; Lapidus, RG; Liao, J; Yang, Z | 1 |
| Bian, Y; Chen, Z; Cheng, H; Friedman, J; Han, J; Kannabiran, V; Mohan, S; VanWaes, C; Zhang, L | 1 |
| Carlson, SG; Chen, Z; Cheng, H; Coupar, JF; Eytan, DF; Mohan, S; Pierce, ML; Shah, S; Van Waes, C; Vander Broek, R; Zhang, J | 1 |
| Affolter, A; Freier, K; Hess, J; Lorenz, K; Muller, MF; Perner, S; Plinkert, PK; Sharma, S; Sommer, K; Stenzinger, A; Weber, KJ; Weichert, W; Wolf, J; Wolf, T; Zaoui, K | 1 |
4 other study(ies) available for diphenylamine and Head and Neck Neoplasms
| Article | Year |
|---|---|
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Topics: Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Dasatinib; Diphenylamine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Phosphorylation; Proto-Oncogene Protein c-ets-1; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Up-Regulation | 2019 |
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
Topics: Animals; Benzamides; Blotting, Western; Casein Kinase II; Cell Line, Tumor; Diphenylamine; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred BALB C; Mice, SCID; Naphthyridines; NF-kappa B; Phenazines; Proto-Oncogene Proteins c-fos; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cytokines; Diphenylamine; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Genes, Reporter; Head and Neck Neoplasms; Humans; Inflammation Mediators; Mitogen-Activated Protein Kinase Kinases; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcriptional Activation; Triazines; Xenograft Model Antitumor Assays | 2015 |
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer.
Topics: Adult; Aged; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Female; Head and Neck Neoplasms; Humans; Male; MAP Kinase Signaling System; Middle Aged; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Suppressor Protein p53 | 2016 |